# Bivas Biswas

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bivas-biswas/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,984 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 19 |
| i10-index | 42 |
| Last Known Institution | Apollo Gleneagles Hospitals |
| OpenAlex ID | https://openalex.org/A5011415920 |
| ORCID iD | 0000-0002-6101-5500 |
| Works | 176 |

## Researcher papers

- [Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer](https://scholariq.org/papers/perioperative-durvalumab-for-resectable-non-small-cell-lung-cancer/)
- [Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC](https://scholariq.org/papers/survival-with-osimertinib-plus-chemotherapy-in-i-egfr-i-mutated-advanced-nsclc/)
- [Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma](https://scholariq.org/papers/evaluation-of-outcome-and-prognostic-factors-in-extraosseous-ewing-sarcoma/)
- [Management of Ewing sarcoma family of tumors: Current scenario and unmet need](https://scholariq.org/papers/management-of-ewing-sarcoma-family-of-tumors-current-scenario-and-unmet-need/)
- [Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer](https://scholariq.org/papers/differential-clinicopathological-features-treatments-and-outcomes-in-patients/)
- [Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India](https://scholariq.org/papers/perspective-of-oncology-patients-during-covid-19-pandemic-a-prospective/)
- [Hypoalbuminaemia is an Independent Predictor of Poor Outcome in Metastatic Ewing's Sarcoma Family of Tumours: A Single Institutional Experience of 150 Cases Treated with Uniform Chemotherapy Protocol](https://scholariq.org/papers/hypoalbuminaemia-is-an-independent-predictor-of-poor-outcome-in-metastatic-ewing/)
- [Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets](https://scholariq.org/papers/low-dose-abiraterone-in-metastatic-prostate-cancer-is-it-practice-changing-facts/)
- [Prognostic factors in head and neck Ewing sarcoma family of tumors](https://scholariq.org/papers/prognostic-factors-in-head-and-neck-ewing-sarcoma-family-of-tumors/)
- [Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol](https://scholariq.org/papers/developing-a-prognostic-model-for-localized-ewing-sarcoma-family-of-tumors-a/)
- [1339P Real-world experience of dacomitinib in mEGFR Advanced NSCLC: A single centre experience](https://scholariq.org/papers/1339p-real-world-experience-of-dacomitinib-in-megfr-advanced-nsclc-a-single/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Apollo Gleneagles Hospitals](https://scholariq.org/institutions/apollo-gleneagles-hospitals/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.